Cardiologie

De vakgroep beoefent de cardiologie in al haar diagnostische en therapeutische mogelijkheden.

Er is een 24 uur/7 dagen per week STEMI-zorg voor het adherentiegebied van het ASz en Beatrixziekenhuis.

De interventiecardiologen doen meer dan 1200 PCI’s jaarlijks. Er bestaat een samenwerkingsverband met het Beatrixziekenhuis in Gorinchem voor de interventiecardiologie, niet-invasieve beeldvorming, ICD en cardiale resynchronisatietherapie. Er bestaat tevens een samenwerkingsverband met het Erasmus MC op het gebied van de electrofysiologie, thoraxchirurgie, interventiecardiologie, de B-opleiding cardiologie en behandeling van congenitale hartziekten.

Er lopen verschillende onderzoekslijnen met origineel wetenschappelijk onderzoek. Samen met de vakgroep radiologie wordt cardiaal MRI- en CT-onderzoek verricht. Er is een vermelding op de witte lijst van de NVVC voor zowel de percutane coronaire interventies als ICD-implantaties. Procedure data en follow-up van zowel PM/ICD’s als PCI’s worden geregistreerd in de landelijke NCDR database. Er is een level 3 IC in het ASz.

Leden

M. (Micon) Bijl

M. (Micon) Bijl

Cardiologie

BIG: 29020421101

dr. E.J. (Ewout-Jan) van den Bos

dr. E.J. (Ewout-Jan) van den Bos

Cardiologie

BIG: 29057046501

A. (Attila) Dirkali

A. (Attila) Dirkali

Cardiologie

BIG: 09044772601

dr. M.W.F. (Marco) van Gent

dr. M.W.F. (Marco) van Gent

Cardiologie

BIG: 29060453001

M.J.M. (Maurice) Kurvers

M.J.M. (Maurice) Kurvers

Cardiologie

BIG: 59049084501

M. (Martijn) Scholte

M. (Martijn) Scholte

Cardiologie

BIG: 49057968601

A.P.J.D. (Auke) Weevers

A.P.J.D. (Auke) Weevers

Cardiologie

BIG: 79058214901

dr. L.J.P.M. (Léon) van Woerkens

dr. L.J.P.M. (Léon) van Woerkens

Cardiologie

BIG: 39041690401

A.M. (Anne Mijntje) Helming

A.M. (Anne Mijntje) Helming

Cardiologie, medisch manager vakgroep

BIG: 69065887501

C. (Crista) Liesting

C. (Crista) Liesting

Cardiologie

BIG: 69909135001

dr. F. (Floris) Kauer

dr. F. (Floris) Kauer

Interventiecardiologie

BIG: 99059681201

dr. J.O. (John) Younge

dr. J.O. (John) Younge

Cardiologie (aandachtsgebied hartfalen)

BIG: 89915145301

J.M. (Jin) Cheng

J.M. (Jin) Cheng

Interventiecardiologie

BIG: 89915153301

dr. V.V. (Veemal) Hemradj

dr. V.V. (Veemal) Hemradj

Interventiecardioloog

Dordwijk

Publicaties

01mrt

The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome.

01feb

The predictive value of the PRAETORIAN score for defibrillation test success in subcutaneous ICD patients: a sub-analysis of the PRAETORIAN-DFT trial.

01jan

Acute Coronary Syndrome Subphenotypes Based on Repeated Biomarker Measurements in Relation to Long-Term Mortality Risk.

01nov

Use of loop diuretics in patients with chronic heart failure: an observational overview.

01okt

Routine transthoracic echocardiography in ischaemic stroke or transient ischaemic attack of undetermined cause: a prospective multicentre study.

01sep

Treatment of elderly patients with non-ST-elevation myocardial infarction: the nationwide POPular age registry.

01sep

Fractional Flow Reserve-Negative High-Risk Plaques and Clinical Outcomes After Myocardial Infarction

01jul

Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohort.

01jun

Impact of Multisite artery disease on Clinical Outcomes After Percutaneous Coronary Intervention: An Analysis from the e-Ultimaster Registry.

01mei

Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial.

01apr

Serially Measured hs-cTnT, NT-proBNP, hs-CRP and GDF-15 for Risk Assessment After Acute Coronary Syndrome: the BIOMArCS Cohort.

01apr

Mitochondrial Cardiomyopathy: Distinctive Cardiac Phenotype Detected with Cardiovascular MRI.

01mrt

Regional management of worsening heart failure: rationale and design of the CHAIN-HF registry.

01mrt

Sex-related bleeding risk in acute coronary syndrome patients receiving dual antiplatelet therapy with aspirin and a P2Y12 inhibitor.

01mrt

Risk of cancer after ST-segment-elevation myocardial infarction.

01jan

Multimarker analysis of serially measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and prognosis in acute heart failure.

01jan

Longitudinal profile of circulating endothelial cells in post-acute coronary syndrome patients.

01dec

A rare finding on computed tomography angiography performed to exclude pulmonary embolism.

01dec

Pharmaco-invasive therapy: Early implementation of statins and proprotein convertase subtilisin/kexin type 9 inhibitors after acute coronary syndrome.

01nov

Prognostic value of syntax score, intravascular ultrasound and near-infrared spectroscopy to identify low-risk patients with coronary artery disease 5-year results from the ATHEROREMO and IBIS-3 cohorts.

01nov

Multimarker analysis of serially measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and prognosis in acute heart failure.

01nov

Morphological characteristics of lesions with thin cap fibroatheroma-a substudy from the COMBINE (OCT-FFR) trial.

01nov

Final 5-year report of the randomized BIO-RESORT trial comparing 3 contemporary drug-eluting stents in all-comers.

01sep

Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma.

01aug

The effect of trastuzumab on cardiac function in patients with HER2-positive metastatic breast cancer and reduced baseline left ventricular ejection fraction.

01aug

The effect of trastuzumab on cardiac function in patients with HER2-positive metastatic breast cancer and reduced baseline left ventricular ejection fraction.

01aug

Clinical Outcomes of Percutaneous Coronary Intervention for Bifurcation Lesions According to Medina Classification.

01jun

Predictive Value of the (Quick)DASH Tool for Upper Extremity Dysfunction Following Percutaneous Coronary Intervention.

01mei

Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights From the COMBINE OCT-FFR Trial.

01apr

The effect of trastuzumab on cardiac function in patients with HER2-positive metastatic breast cancer and reduced baseline left ventricular ejection fraction.

01mrt

Treatment and Management of Upper Extremity Dysfunction Following Transradial Percutaneous Coronary Intervention: A Prospective Cohort Study.

01mrt

Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial.

01jan

Relation of Iron Status to Prognosis After Acute Coronary Syndrome.

Beeldmateriaal

of login met gebruikersnaam